Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review

Masoumeh Mohamadi1, Azadeh Goodarzi1, Armin Aryannejad2

  • 1Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Insights

Elderly individuals are at higher risk for severe COVID-19 complications, including organ damage. Preventive care and social support are crucial for managing the disease in this vulnerable population.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Public Health

Background:

  • Elderly individuals (65+) face increased susceptibility to SARS-CoV-2 complications due to immune system changes and comorbidities.
  • A significant proportion of COVID-19 mortality occurs in the elderly population.
  • Understanding COVID-19 complications in older adults is critical for public health strategies.

Purpose of the Study:

  • To systematically evaluate the complications of COVID-19 infection specifically in elderly patients.
  • To identify prevalent organ system involvement in older adults with SARS-CoV-2.
  • To inform preventive and management strategies for COVID-19 in geriatric populations.

Main Methods:

  • A systematic review adhering to MOOSE guidelines was performed.
  • Searches were conducted across major databases (PubMed, Scopus, Google Scholar, Science Direct) for relevant literature.
  • Keywords included "SARS-CoV-2", "elderly", "geriatrics", and "comorbidity".

Main Results:

  • Review of 35 articles revealed prevalent organ damage in the pulmonary, cardiovascular, liver, and renal systems among elderly COVID-19 patients.
  • Multiorgan involvement is a common concern in this demographic.
  • Preventive, multidisciplinary, and holistic assessments are vital for mitigating severe outcomes.

Conclusions:

  • Increased attention and tailored support are necessary for elderly individuals during quarantine.
  • Maintaining social connections via digital means and ensuring access to food and medication are essential.
  • Social and volunteer services can significantly support the mental well-being of elderly patients lacking social networks.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
99
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
105
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
86
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
95
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
72
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
147